← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Oncoscope, Inc.
Durham, NC
$3,265,818
Total funding
3
Grants
Funding over time
peak $1M · FY2009–13$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$2,987,964 · 1
NSF$277,854 · 2
By mechanism
R44$2,987,964 · 1
—$277,854 · 2
Investigators at Oncoscope, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Validation and commercialization of a/LCI for detection of esophageal neoplasia$1,000,000
R44 · FY2011 · CA
Validation and commercialization of a/LCI for detection of esophageal neoplasia$980,392
R44 · FY2012 · CA
Validation and commercialization of a/LCI for detection of esophageal neoplasia$912,907
R44 · FY2013 · CA
SBIR Phase I: Large Area Scanning Angle-resolved Low Coherence Interferometry (a/LCI) for Endoscopic Precancer Detection$149,920
· FY2010 · TIP
SBIR Phase I: Innovation for an Easy to Use Clinical a/LCI System for in Vivo Detection of Precancer$127,934
· FY2009 · TIP
Clinical validation of a/LCI for detecting pre-cancerous lesions in the esophagus$94,665
R44 · FY2010 · CA